How much funding has RADIKAL THERAPEUTICS, INC. raised?

RADIKAL THERAPEUTICS, INC. has raised $15.9M in total funding, most recently a Grant round.

Who are RADIKAL THERAPEUTICS, INC.'s investors?

RADIKAL THERAPEUTICS, INC.'s investors include HHS.

When was RADIKAL THERAPEUTICS, INC. founded?

RADIKAL THERAPEUTICS, INC. was founded in 2015.

Where is RADIKAL THERAPEUTICS, INC. headquartered?

RADIKAL THERAPEUTICS, INC. is headquartered in WEST TISBURY, Massachusetts, United States.

What industry is RADIKAL THERAPEUTICS, INC. in?

RADIKAL THERAPEUTICS, INC. operates in Biotech, Healthcare.

RADIKAL THERAPEUTICS, INC.

WEST TISBURY, United States · Founded 2015 · $15.9M raised

Biotech

Healthcare

Headquarters: WEST TISBURY, Massachusetts
Founded: 2015
Business Model: B2B

Total Funding: $15.9M
Last Round: $15.9M GrantOct 2016
Rounds: 1

About

Radikal Therapeutics is a biotechnology company focused on the discovery and development of small molecule pharmaceuticals for eye, lung, and renal diseases. Its lead program, R-801, is a novel bifunctional prodrug targeting K+-ATP channel activation for treatment of primary open angle glaucoma. The company conducts research through SBIR-funded programs from the National Institutes of Health.

Summary

RADIKAL THERAPEUTICS, INC. is a Biotech company based in WEST TISBURY, United States, founded in 2015. It has raised $15.9M in total across 1 round, most recently a $15.9M Grant round in Oct 2016. Investors include HHS.